LU74763A1 - - Google Patents

Info

Publication number
LU74763A1
LU74763A1 LU74763A LU74763A LU74763A1 LU 74763 A1 LU74763 A1 LU 74763A1 LU 74763 A LU74763 A LU 74763A LU 74763 A LU74763 A LU 74763A LU 74763 A1 LU74763 A1 LU 74763A1
Authority
LU
Luxembourg
Application number
LU74763A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU74763A1 publication Critical patent/LU74763A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
LU74763A 1975-04-18 1976-04-14 LU74763A1 (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752517771 DE2517771A1 (de) 1975-04-18 1975-04-18 Neue prostaglandin-acetylen-analoga und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
LU74763A1 true LU74763A1 (ko) 1977-01-12

Family

ID=5944669

Family Applications (1)

Application Number Title Priority Date Filing Date
LU74763A LU74763A1 (ko) 1975-04-18 1976-04-14

Country Status (15)

Country Link
US (1) US4073934A (ko)
JP (1) JPS51131860A (ko)
AT (1) AT360182B (ko)
AU (1) AU510088B2 (ko)
BE (1) BE840872A (ko)
CA (1) CA1079725A (ko)
CH (1) CH626876A5 (ko)
DE (1) DE2517771A1 (ko)
DK (1) DK142976A (ko)
FR (1) FR2307525A1 (ko)
GB (1) GB1549047A (ko)
IE (1) IE43600B1 (ko)
LU (1) LU74763A1 (ko)
NL (1) NL7604016A (ko)
SE (1) SE7604409L (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2517772A1 (de) * 1975-04-18 1976-10-28 Schering Ag Cyclopentanderivate und verfahren zu ihrer herstellung
US4268522A (en) * 1976-06-14 1981-05-19 Pfizer Inc. 13,14-Dihydro-15-alkenyl- and 13,14-dihydro-15-alkynyl prostaglandins and analogs thereof
DE2729960A1 (de) * 1977-06-30 1979-01-18 Schering Ag Neue acetylenprostaglandine und verfahren zu ihrer herstellung
JPS6033429B2 (ja) * 1980-04-28 1985-08-02 小野薬品工業株式会社 プロスタグランジン類似化合物
GB2225573A (en) * 1988-09-16 1990-06-06 Ueno Seiyaku Oyo Kenkyujo Kk 13,14-dihydro-15-keto-PGFs
EP1012137B1 (en) * 1997-09-09 2002-11-06 The Procter & Gamble Company Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
US5977173A (en) * 1997-09-09 1999-11-02 Wos; John August Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists
AU3861700A (en) * 1999-03-05 2000-09-21 Procter & Gamble Company, The Aldehyde intermediates for the preparation of prostaglandin derivatives
NZ513825A (en) * 1999-03-05 2001-09-28 Procter & Gamble C 16 unsaturated FP-selective prostaglandins analogs
US6894175B1 (en) * 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020013294A1 (en) * 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US7632078B2 (en) * 2003-10-30 2009-12-15 Deka Products Limited Partnership Pump cassette bank
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
JP6141430B2 (ja) 2012-07-19 2017-06-07 ケイマン ケミカル カンパニー， インコーポレーテッド Ｅｐ４介在性骨関連疾患及び病態用ジフルオロラクタム組成物
WO2014144500A2 (en) 2013-03-15 2014-09-18 Cayman Chemical Company, Inc. Methods of synthesizing a difluorolactam analog
KR20150130326A (ko) 2013-03-15 2015-11-23 카이맨 케미칼 컴파니 인코포레이티드 Ep4-매개 질환 및 병태의 치료에서 사용하기 위한 ep4 수용체 선택적 효현제로서 락탐 화합물
AU2014290512A1 (en) 2013-07-19 2015-11-12 Cayman Chemical Company, Inc. Methods, systems, and compositions for promoting bone growth
SG11201809622VA (en) 2016-05-09 2018-11-29 Agc Inc Novel prostaglandin derivative
WO2019087948A1 (ja) 2017-10-31 2019-05-09 Ａｇｃ株式会社 プロスタグランジン誘導体の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50140427A (ko) * 1974-02-27 1975-11-11

Also Published As

Publication number Publication date
NL7604016A (nl) 1976-10-20
AU510088B2 (en) 1980-06-05
IE43600B1 (en) 1981-04-08
AT360182B (de) 1980-12-29
CA1079725A (en) 1980-06-17
DE2517771A1 (de) 1976-10-28
FR2307525B1 (ko) 1980-11-28
IE43600L (en) 1976-10-18
JPS51131860A (en) 1976-11-16
BE840872A (fr) 1976-10-18
ATA273976A (de) 1980-05-15
AU1314876A (en) 1977-10-27
DK142976A (da) 1976-10-19
US4073934A (en) 1978-02-14
CH626876A5 (ko) 1981-12-15
SE7604409L (sv) 1976-10-19
GB1549047A (en) 1979-08-01
FR2307525A1 (fr) 1976-11-12

Similar Documents

Publication Publication Date Title
FR2307525B1 (ko)
FR2300557B1 (ko)
JPS5291939U (ko)
JPS539147Y2 (ko)
JPS5412613Y1 (ko)
JPS5438953B2 (ko)
JPS5621104B2 (ko)
JPS5261147U (ko)
JPS5283082U (ko)
JPS51143484U (ko)
JPS51163790U (ko)
JPS5268000U (ko)
JPS5215251U (ko)
CH606837A5 (ko)
CH429375A4 (ko)
CH602313A5 (ko)
BG22264A1 (ko)
DD117688A1 (ko)
CH607659A5 (ko)
CH607456A5 (ko)
CH607308A5 (ko)
CH606982A5 (ko)
CH577290A5 (ko)
CH606700A5 (ko)
BG22613A1 (ko)